Prof. Dr. Georg Schett

Prof. Dr. Georg Schett was promoted to professor of Internal Medicine in 2003, following his postgraduate training in Internal Medicine and specialized focus in Rheumatology at the Department of Medicine at the University of Vienna. His foundational scientific work investigated the immunology of atherosclerosis and antibody-mediated endothelial cell damage, culminating in a better understanding of LE-cells in 2007.

This early research laid the groundwork for his comprehensive contributions to understanding immune-inflammatory diseases. Since 2006, Prof. Dr. Schett has served as the head of the Department of Medicine 3 — Rheumatology and Immunology at Uniklinikum Erlangen, part of the Friedrich-Alexander-Universität Erlangen-Nürnberg in Germany.

Under his leadership, the department has become a center for advanced research into the molecular underpinnings of immune-inflammatory diseases. In 2008, he co-initiated the IMMUNOBONE priority program, funded by the German Research Foundation (DFG), which explores the critical interactions between skeletal and immune systems. Building on this, since 2015, he has led the DFG collaborative research centre 1181 ‘Checkpoints for Resolution of Inflammation’ in Erlangen and serves as spokesperson for the METARTHROS project, funded by the Federal Ministry of Education and Research, examining metabolism’s impact on arthritis. In 2019, Prof.

Dr. Schett has published over 1100 peer-reviewed papers, solidifying his standing as a leading voice in rheumatology and immunology. His extensive contributions have garnered numerous accolades, including the esteemed Carol-Nachman Prize. Most recently, in 2023, he was awarded the ‘Funding Prize in the Gottfried Wilhelm Leibniz Programme’ from the German Research Foundation (DFG, one of the highest honors in German research.